Author

Liudeng Zhang

The University of Texas MD Anderson Cancer CenterORCID 0009-0009-4530-4685Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Liudeng Zhang1 paper · Central South University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Guofeng CheniD· 1 shared Han LiangiD· 1 shared Jian Chen· 1 shared Jing Chen· 1 shared Ke CheniD· 1 shared Lie WangiD· 1 shared Muxing KangiD· 1 shared Qiaowei Lin· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Guofeng ChenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CEACAM5/6+ Tumor Cells and IL-1β+ Macrophages Drive Resistance to Chemo-immunotherapy in Gastric Cancer

Jian Chen, Liudeng Zhang, Yikai Luo, Xu Han, Muxing Kang, Jing Chen, Wei Liu, Zhenzhen Xun, Guofeng Chen, Ke Chen, Shenbin Xu, Yu Zhang, Zhiwei Wu, Wenxuan Wu, Z. R. Hao, , Han Liang

The paper identifies two resistance mechanisms in gastric cancer to chemo-immunotherapy, involving CEACAM5/6+ tumor cells and IL-1β+ macrophages, and suggests them as biomarkers and therapeutic targets.

bioRxiv · Mar 8, 2026 · PreprintCancer Biology